Search

Your search keyword '"Mortensen, J. H."' showing total 65 results

Search Constraints

Start Over You searched for: Author "Mortensen, J. H." Remove constraint Author: "Mortensen, J. H."
65 results on '"Mortensen, J. H."'

Search Results

6. P242 Immune-cell specific biomarker of early intestinal inflammation: Neutrophil elastase degraded fragment of type III collagen is elevated in patients with Inflammatory Bowel Disease

10. Femoral & Experimental

11. P611 Serological biomarkers of type VI and XXII collagen formation predict and monitor infliximab treatment response in patients with Crohn’s disease

12. P127 Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel Disease

13. P460 Biomarkers reflecting extracellular matrix turnover and inflammation can be used to monitor disease activity and treatment response in patients with Crohn’s disease undergoing infliximab induction therapy

14. P394 Serological biomarkers of type III and IV collagen remodeling predict and monitor infliximab treatment response in patients with Inflammatory Bowel Disease

15. P123 Type I collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn’s disease

16. P278 Type IV collagen formation/degradation ratio predicts response to infliximab induction therapy in patients with Ulcerative Colitis

17. Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease

22. Extracellular matrix fragments of the basement membrane and the interstitial matrix are markers of disease activity and disease progression

23. Basement membrane remodelling as a biomarker for monitoring disease activity in Crohn's disease patients: the role of laminin

24. Serum biomarkers reflecting tissue-remodelling correlates with the simple endoscopic score for Crohn's disease

25. Serological assessment of type XVI collagen reflects intestinal strictures in Crohn's disease patients

26. Serological biomarkers of tissue turnover can early identify responders to infliximab in Crohn's disease

27. Early suppression of the serological macrophage activity biomarker VICM, and not suppression of CRP, predicts the response to infliximab in Crohn's disease patients

34. Type V Collagen is Persistently Altered After Inguinal Hernia Repair

35. MMP degraded type III collagen is a novel serological biomarker for penetrating (Montreal B3) Crohn's disease

44. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.

46. Optimization of Boiler Control to Improve the Load-following Capability of Power-plant Units

47. Development of an Optimizing Control Concept for Fossil-Fired Boilers using a Simulation Model

48. Kontrolstrategi til frigørelse af kraftværkers reguleringsevne

49. Optimization of Boiler Control for Improvement of Load Following Capabilities of Existing Power Plants

Catalog

Books, media, physical & digital resources